Dopamine Hydrochloride Injection Shortage
Manufacturers report shortage status per product/package to the FDA independently, so the same generic drug can be short from one company while another still has supply -- the table below breaks that down company by company.
| Company | Brand name | Status | Last updated |
|---|---|---|---|
| Hospira, Inc., a Pfizer Company | DOPAMINE HYDROCHLORIDE IN DEXTROSE | To Be Discontinued | 08/27/2025 |
| Hospira, Inc., a Pfizer Company | — | Current | 07/23/2026 |
| Hospira, Inc., a Pfizer Company | DOPAMINE HYDROCHLORIDE IN DEXTROSE | Current | 07/23/2026 |
| Hospira, Inc., a Pfizer Company | DOPAMINE HYDROCHLORIDE | Current | 07/23/2026 |
| Hospira, Inc., a Pfizer Company | DOPAMINE HYDROCHLORIDE | Current | 07/23/2026 |
| Baxter Healthcare | DOPAMINE HYDROCHLORIDE AND DEXTROSE | Current | 07/19/2026 |
| Baxter Healthcare | DOPAMINE HYDROCHLORIDE AND DEXTROSE | Current | 07/19/2026 |
| Baxter Healthcare | DOPAMINE HYDROCHLORIDE AND DEXTROSE | Current | 07/19/2026 |
| Baxter Healthcare | DOPAMINE HYDROCHLORIDE AND DEXTROSE | Current | 07/19/2026 |
| Hikma Pharmaceuticals USA, Inc. | DOPAMINE HYDROCHLORIDE | Current | 07/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | DOPAMINE HYDROCHLORIDE | Current | 07/13/2026 |